Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnocellular neurosecretory cells are large neuroendocrine neurons located primarily in the supraoptic nucleus (SON) and the paraventricular nucleus (PVN) of the hypothalamus. These cells are responsible for the synthesis of the peptide hormones oxytocin and arginine vasopressin (also known as antidiuretic hormone), which are transported along axons to the posterior pituitary gland for systemic secretion into the bloodstream [1][2]. They play a fundamental role in maintaining physiological homeostasis, specifically regulating fluid balance and osmotic pressure through vasopressin and facilitating reproductive functions like labor and milk let-down through oxytocin [3][4]. While 'Magnocellular neurons' represent a cellular population rather than a single molecular target, they are the primary source of hormones involved in significant clinical conditions such as central diabetes insipidus and SIADH [5]. Therapeutic interventions often involve synthetic analogs of their secreted hormones, such as desmopressin, or antagonists that block their effects at peripheral receptors, such as vaptans [2][6]. Furthermore, these neurons are subject to complex feedback loops and modulation by various neurotransmitters, making them a focal point for understanding neuroendocrine integration [4]. Sources: [1] StatPearls, 'Physiology, Vasopressin', NIH. [2] StatPearls, 'Syndrome of Inappropriate Antidiuretic Hormone Secretion', NIH. [3] Journal of Neuroendocrinology, 'The magnocellular neurosecretory system'. [4] Wikipedia, 'Magnocellular neurosecretory cell'. [5] PubMed, 'Hypothalamic magnocellular neurons: osmotic and hormonal regulation'. [6] NIH, 'Vasopressin and Oxytocin: From Genes to Function'.
Drugs typically target the hormonal products of these cells or their downstream receptors; for instance, vasopressin V2 receptor agonists treat diabetes insipidus, while V2 antagonists treat hyponatremia. Some substances like ethanol or morphine directly modulate the firing rates and hormone release from these neurons.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnocellular neurosecretory cell (MNC).